Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): Updated results from a phase 1/2 study Meeting Abstract


Authors: Popat, S.; Ramalingam, S.; Zhou, C.; Kim, T.; Yang, J.; Riely, G.; Mekhail, T.; Nguyen, D.; Campelo, M. R. G.; Felip, E.; Misch, D.; Kaur, M.; Bunn, V.; Lin, H.; Zhang, P.; Jänne, P.
Abstract Title: Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): Updated results from a phase 1/2 study
Meeting Title: 21st Annual Conference of the British Thoracic Oncology Group (BTOG)
Journal Title: Lung Cancer
Volume: 178
Issue: Suppl. 1
Meeting Dates: 2023 Apr 26-28
Meeting Location: Belfast, Ireland
ISSN: 0169-5002
Publisher: Elsevier Ireland Ltd.  
Date Published: 2023-04-01
Start Page: S35
Language: English
ACCESSION: WOS:000995413600081
PROVIDER: wos
DOI: 10.1016/S0169-5002(23)00508-1
Notes: Meeting Abstract: 81 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely